Filings

3 documents · 25 matches

1. INTI Inhibitor Therapeutics, Inc. 10-K 2026-03-26

   Item 16. Form 10-K Summary.

   going concern. As discussed in Note 2 to the financial statements, the Company is not profitable, has recorded negative cash
   12 matches in this document Show context Copy citation

2. INTI Inhibitor Therapeutics, Inc. 10-Q 2026-08-14

   Item 6. Exhibits 18

   going concern. However, there can be no assurances that the proceeds will be received pursuant to the securities purchase agreement
   7 matches in this document Show context Copy citation

3. INTI Inhibitor Therapeutics, Inc. 10-Q 2026-05-15

   Item 6. Exhibits 14

   going concern. However, there can be no assurances that the proceeds will be received pursuant to the securities purchase agreement
   6 matches in this document Show context Copy citation